Nepsis Inc’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.92M Buy
2,976,187
+1,099,898
+59% +$1.59M 2.01% 21
2026
Q1
$2.38M Sell
1,876,289
-39,505
-2% -$74.3K 0.8% 24
2025
Q4
$4.58M Buy
1,915,794
+402,762
+27% +$1.1M 1.41% 23
2025
Q3
$4.31M Sell
1,513,032
-212,033
-12% -$726K 1.37% 23
2025
Q2
$6.5M Sell
1,725,065
-365,747
-17% -$1.44M 1.81% 23
2025
Q1
$9.47M Buy
2,090,812
+1,994,555
+2,072% +$10.6M 2.34% 22
2024
Q4
$10.1M Sell
96,257
-2,008,271
-95% -$16M 2.53% 21
2024
Q3
$17.1M Buy
2,104,528
+851,448
+68% +$6.15M 4.06% 13
2024
Q2
$8.01M Buy
1,253,080
+95,686
+8% +$614K 2.16% 20
2024
Q1
$8.72M Buy
1,157,394
+65,462
+6% +$598K 2.36% 21
2023
Q4
$10.1M Buy
1,091,932
+186,128
+21% +$1.52M 2.88% 20
2023
Q3
$9.17M Buy
905,804
+63,065
+7% +$753K 2.81% 21
2023
Q2
$10.5M Buy
842,739
+49,160
+6% +$585K 3.25% 19
2023
Q1
$9.26M Sell
793,579
-188,702
-19% -$2.41M 3.08% 20
2022
Q4
$10.4M Buy
982,281
+155,440
+19% +$1.5M 3.5% 15
2022
Q3
$8.02M Buy
+826,841
New +$10.9M 2.9% 19
2022
Q1
Sell
-245,186
Closed -$9.71M 33
2021
Q4
$9.71M Buy
245,186
+30,032
+14% +$1.37M 2.82% 19
2021
Q3
$10.8M Buy
215,154
+3,948
+2% +$215K 3.39% 17
2021
Q2
$11.7M Sell
211,206
-11,425
-5% -$609K 3.71% 14
2021
Q1
$10.4M Buy
222,631
+21,985
+11% +$1.06M 3.3% 17
2020
Q4
$8.73M Buy
200,646
+3,468
+2% +$128K 3.18% 16
2020
Q3
$7.22M Sell
197,178
-11,923
-6% -$405K 3.46% 14
2020
Q2
$6.1M Sell
209,101
-5,340
-2% -$148K 2.95% 21
2020
Q1
$5.61M Buy
214,441
+97,728
+84% +$2.99M 3.75% 16
2019
Q4
$4.18M Buy
116,713
+8,011
+7% +$265K 2.12% 25
2019
Q3
$3.1M Buy
+108,702
New +$4.28M 1.79% 27

Other funds holding HCAT